Pyxis Biologix Inc. is a private biotechnology company based out of Irvine, CA. Founded in 2011, the company specializes in manufacturing proprietary recombinant proteins, peptides, and other small organic molecules, and researching their unique secretagogue properties. These compounds occur naturally in the body and are vital for communication and coordination of bodily functions. In instances of disease, the body's ability to produce these compounds is impaired. The company's aim is to identify and develop peptides and proprietary blends to aid the body in combatting disease and returning to a state of physiological balance. Collaborations within the biomedical field are sought to develop proprietary peptides with beneficial indications. It's important to note that all peptides are designed for in vitro purposes and are blended into a transdermal gel for research use only. Pyxis Biologix fosters an open and authentic work culture, encouraging creativity, friendship, and collaboration. The company is positioned within the Biotechnology and Pharmaceutical industries, presenting a unique opportunity for potential investors.
Based in Irvine, CA, and founded in 2011, Pyxis Biologix Inc. is a versatile player in the biotechnology and pharmaceutical spaces. The company's focus on researching and developing peptides and proprietary blends provides an innovative approach to addressing disease states and returning the body to a state of balance. With an emphasis on collaboration within the biomedical field, Pyxis Biologix represents an appealing prospect for potential investors seeking opportunities in the biotechnology sector.
There is no investment information
No recent news or press coverage available for Pyxis Biologix Inc..